Infarct Growth Rate Predicts Early Neurological Improvement in Ischemic Stroke After Endovascular Thrombectomy

Background and Purpose: The infarct growth rate (IGR) is a major modifier of the therapeutic effect of endovascular thrombectomy. The objective of this paper was to explore the utility of the IGR measured by perfusion the imaging in predicting early neurological improvement (ENI) of patients treated...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhihang Huang, Shuaiyu Chen, Bin Wei, Yan E, Jingwen Qi, Xiaohao Zhang, Teng Jiang
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/15/3/303
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Purpose: The infarct growth rate (IGR) is a major modifier of the therapeutic effect of endovascular thrombectomy. The objective of this paper was to explore the utility of the IGR measured by perfusion the imaging in predicting early neurological improvement (ENI) of patients treated with EVT. Methods: We reviewed consecutive large vessel occlusive stroke in the anterior circulation and treated by thrombectomy between October 2019 to July 2024. The IGR was defined as the ischemic core volume (apparent diffusion coefficient ≤ 620 × 10<sup>−6</sup> mm<sup>2</sup>/s or relative cerebral blood flow < 30%) divided by the time from stroke onset to imaging. ENI was defined as a reduction ≥ 6 points in the NIH Stroke Scale score at 24 h after the procedure, or an NIH Stroke Scale score of 0 or 1 on day 7 of hospitalization or at discharge if it occurred before day 7. Results: A total of 407 patients (mean age, 69.3 ± 12.5 years; 63.1% of male) were included, of whom 149 (36.6%) achieved ENI. Among all enrolled patients, 281 patients were classified as slow (IGR < 10 mL/h) and 126 fast progressors (IGR ≥ 10 mL/h). In multivariable analyses, fast progressors had a lower likelihood of achieving ENI after endovascular thrombectomy (odds ratio, 0.442; 95% confidence intervals, 0.269–0.729, <i>p</i> = 0.001) as compared to slow progressors. Subgroup analyses further confirmed these results. Furthermore, the odds of ENI decreased by 7.3% for each 5 mL/h increase in the IGR (odds ratio, 0.927; 95% confidence intervals, 0.875–0.982, <i>p</i> = 0.011). Conclusions: The present study found that the pre-treatment IGR was associated with ENI in thrombectomy patients.
ISSN:2076-3425